No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Thursday, March 03, 2016

No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing



abstract

 Conclusions These results suggest that truncating variants in BRIP1, and in particular p.Arg798Ter, are not associated with a substantial increase in breast cancer risk. Such observations have important implications for the reporting of results from breast cancer screening panels.

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.